In a study published in Cell Stem Cell, scientists tested retinal pigment epithelial stem cells in a phase 1/2a clinical trial. The cells were obtained from adult postmortem eye tissue. These ...

Kavita Nair, PhD, FAAN, shares how new therapies and ongoing clinical trials are reshaping the future of neurological care and offering new hope to patients.

A first-of-its-kind trial is testing adult stem cell transplants for advanced dry macular degeneration. Early results show ...

By reducing inflammation, the researchers were able to prevent both the buildup of immune cells and the formation of these ...

University of Minnesota Medical School researchers have shown that reducing chronic inflammation can significantly protect ...

Genetic predisposition to rheumatoid arthritis increases the risk of interstitial lung disease by 15.5%, as shown by Mendelian randomization analysis. The study used 52 single nucleotide polymorphisms ...

Good morning, and welcome to the Jefferies 2025 Healthcare Conference. It's my pleasure now to introduce David Kirn, CEO; and Chris Simms, Chief Commercial Officer of 4D Molecular Therapeutics. All ...

More than a third of older Singaporean adults have undiagnosed age-related eye diseases, increasing visual impairment risk.

University of Minnesota Medical School researchers have shown that reducing chronic inflammation can significantly protect against age-related macular degeneration (AMD)-like pathology in preclinical ...

Panelists discuss how differing disease mechanisms, inflammatory drivers, and clinical priorities across AMD, DME, and RVO ...

EyePoint Pharmaceuticals' DURAVYU trials for wet AMD receive positive DSMC review, highlighting safety and potential for ...

Abstract: Brain hyper-networks as a kind of hypergraph for brain network analysis, describing the high-order interactions among brain regions, have been extensively utilized in research on brain ...